Series D - Freenome
Investment Firm
Overview
Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.
Announced Date
Dec 07, 2021
Funding Type
Series D
Highlights
Location
United States, North America
Social
Investor Lead
RA Capital Management
RA Capital Management is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.
Perceptive Advisors
Perceptive Advisors is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.
Participant Investors
27
Round Details and Background
Freenome raised $300000000 on 2021-12-07 in Series D
Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 15, 2024 |  Venture Round - Freenome | 20 | - | 254.0M |
| Aug 28, 2017 | Series A - Freenome | 12 | - | 7.0M |
| Mar 01, 2017 | Series A - Freenome | 12 | - | 65.0M |
| Jun 09, 2016 | Seed Round - Freenome | 4 | - | 5.5M |
Recent Activity
There is no recent news or activity for this profile.